Rise and Persistence of Global M1T1 Clone of Streptococcus pyogenes

M1T1 strain, its diversification by phage acquisition, and the in vivo selection of more fit members of its community present an intriguing example of the emergence of hypervirulent forms of a human pathogen.

[1]  J. McArthur,et al.  Is plasminogen deployed as a Streptococcus pyogenes virulence factor? , 2005, Trends in microbiology.

[2]  P. Schlievert,et al.  Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. , 1987, The New England journal of medicine.

[3]  B. Schwartz,et al.  Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome , 1993, Infection and immunity.

[4]  E. Kaplan,et al.  Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome , 1991, Journal of clinical microbiology.

[5]  J. Vuopio‐Varkila,et al.  Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. , 1997, The Journal of infectious diseases.

[6]  Adeline R. Whitney,et al.  Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Ramy K. Aziz,et al.  DNase Expression Allows the Pathogen Group A Streptococcus to Escape Killing in Neutrophil Extracellular Traps , 2006, Current Biology.

[8]  D. Morens,et al.  Severe streptococcal infections in historical perspective. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  B. Schwartz,et al.  The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. , 1993, JAMA.

[10]  M. Markowitz.  Changing epidemiology of group A streptococcal infections , 1994, The Pediatric infectious disease journal.

[11]  Bruce A. Roe,et al.  Complete genome sequence of an M1 strain of Streptococcus pyogenes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Schlievert,et al.  SEVERE GROUP A STREPTOCOCCAL INFECTIONS ASSOCIATED WITH A TOXIC SHOCK-LIFE SYNDROME AND SCARLET FEVER TOXIN , 1990 .

[13]  J. Musser,et al.  Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease , 1995, Infection and immunity.

[14]  Characteristics of Streptococcus pyogenes Serotype M1 and M3 Isolates from Patients in Japan from 1981 to 1997 , 1999, Journal of Clinical Microbiology.

[15]  Rita Kansal,et al.  Invasive M1T1 group A Streptococcus undergoes a phase‐shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB , 2003, Molecular microbiology.

[16]  J. Musser,et al.  Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Tracey,et al.  Autonomous Expression of the slo Gene of the Bicistronic nga - slo Operon of Streptococcus pyogenes , 2002 .

[18]  R. Edwards,et al.  Mosaic Prophages with Horizontally Acquired Genes Account for the Emergence and Diversification of the Globally Disseminated M1T1 Clone of Streptococcus pyogenes , 2005, Journal of bacteriology.

[19]  B. Kreikemeyer,et al.  Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. , 2003, Trends in microbiology.

[20]  H. Watanabe,et al.  Changing prevalent T serotypes and emm genotypes of Streptococcus pyogenes isolates from streptococcal toxic shock-like syndrome (TSLS) patients in Japan , 2003, Epidemiology and Infection.

[21]  E. Hanski,et al.  Invasive Group A Streptococcal Infections, Israel , 2002, Emerging infectious diseases.

[22]  D E Low,et al.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. , 1996, The New England journal of medicine.

[23]  James M. Musser,et al.  Contribution of Exogenous Genetic Elements to the Group A Streptococcus Metagenome , 2007, PloS one.

[24]  W. Tillett,et al.  Streptococcal Desoxyribonuclease , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[25]  R. Kaul,et al.  Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. , 1997, The American journal of medicine.

[26]  Joydeep Ghosh,et al.  Specificity of Streptococcus pyogenes NAD+ glycohydrolase in cytolysin‐mediated translocation , 2006, Molecular microbiology.

[27]  Malak Kotb,et al.  Genetic Relatedness and Superantigen Expression in Group A Streptococcus Serotype M1 Isolates from Patients with Severe and Nonsevere Invasive Diseases , 2000, Infection and Immunity.

[28]  J. Musser,et al.  Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes , 1991, The Journal of experimental medicine.

[29]  Naryttza N. Diaz,et al.  The Subsystems Approach to Genome Annotation and its Use in the Project to Annotate 1000 Genomes , 2005, Nucleic acids research.

[30]  J. Guillaume,et al.  [PubMed]. , 2020, Annales de dermatologie et de venereologie.

[31]  P. Schlievert,et al.  Production of pyrogenic exotoxin by groups of streptococci: association with group A. , 1979, The Journal of infectious diseases.

[32]  V. Nizet,et al.  Trigger for group A streptococcal M1T1 invasive disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[34]  J. Musser,et al.  Virulence control in group A Streptococcus by a two-component gene regulatory system: Global expression profiling and in vivo infection modeling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Caparon,et al.  A role for Trigger Factor and an Rgg‐like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes , 1998, The EMBO journal.

[36]  Malak Kotb,et al.  An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections , 2002, Nature Medicine.

[37]  J. Musser,et al.  Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. , 2005, The Journal of infectious diseases.

[38]  M. Kotb,et al.  Post‐proteomic identification of a novel phage‐encoded streptodornase, Sda1, in invasive M1T1 Streptococcus pyogenes , 2004, Molecular microbiology.

[39]  Edward A Graviss,et al.  Genome-Wide Analysis of Group A Streptococci Reveals a Mutation That Modulates Global Phenotype and Disease Specificity , 2006, PLoS pathogens.

[40]  S. Holm.  Invasive group A streptococcal infections. , 1996, The New England journal of medicine.

[41]  J. Carapetis,et al.  Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. , 2007, The Journal of infectious diseases.

[42]  B. Schwartz,et al.  Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. , 1999, Infection and immunity.

[43]  Dwight R. Johnson,et al.  Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  Dwight R. Johnson,et al.  Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. , 1997, The Journal of infectious diseases.

[45]  R. Kaul,et al.  Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. , 1996, Journal of immunology.

[46]  Dwight R. Johnson,et al.  A comparison of group A streptococci from invasive and uncomplicated infections: are virulent clones responsible for serious streptococcal infections? , 2002, The Journal of infectious diseases.

[47]  P. Cleary,et al.  A Globally Disseminated M1 Subclone of Group A Streptococci Differs from Other Subclones by 70 Kilobases of Prophage DNA and Capacity for High-Frequency Intracellular Invasion , 1998, Infection and Immunity.

[48]  D. Martin,et al.  Molecular epidemiology of group A streptococcus M type 1 infections. , 1993, The Journal of infectious diseases.

[49]  M. Davies,et al.  Inter-species genetic movement may blur the epidemiology of streptococcal diseases in endemic regions. , 2005, Microbes and infection.

[50]  Adeline R. Whitney,et al.  Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  B. Schwartz,et al.  Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  Malak Kotb,et al.  DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection , 2007, Nature Medicine.

[53]  P. Schlievert,et al.  Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s , 1992, The Lancet.

[54]  B. Schwartz,et al.  The Reemergence of Severe Group A Streptococcal Disease: an Evolutionary Perspective , 1998 .

[55]  B. Schwartz,et al.  Changing epidemiology of group A streptococcal infection in the USA , 1990, The Lancet.

[56]  J. Andersson,et al.  Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. , 1999, The Journal of infectious diseases.

[57]  Malak Kotb,et al.  Inverse Relation between Disease Severity and Expression of the Streptococcal Cysteine Protease, SpeB, among Clonal M1T1 Isolates Recovered from Invasive Group A Streptococcal Infection Cases , 2000, Infection and Immunity.

[58]  J. P. Davis,et al.  Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. , 1993, JAMA.